In focus · trending topic

heart

54 stories · following the connections

BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System

By Nasdaq OMXOct 26, 2017, 12:01 PM UTC

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

By Nasdaq OMXOct 24, 2017, 12:00 PM UTC

BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022

By Nasdaq OMXOct 19, 2017, 12:00 PM UTC

BioSig Technologies to Present at the Dawson James Small Cap Growth Conference

By Nasdaq OMXOct 13, 2017, 12:00 PM UTC

Telemedicine Technology Joint Venture Announced Between Cytta Corp and Cardiocomm Solutions

By Nasdaq OMXOct 12, 2017, 11:30 AM UTC

BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer

By Nasdaq OMXOct 11, 2017, 12:00 PM UTC

The Adult Congenital Heart Association (ACHA) Launches National Accreditation Program

By Nasdaq OMXSep 14, 2017, 2:30 PM UTC

BioSig Technologies Enters into Strategic Development Work with Health Research International

By Nasdaq OMXJul 11, 2017, 12:01 PM UTC